Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: Comparison of clinical efficacy and effect on cutaneous substance (P) expression

Journal of Cosmetic Dermatology

Volumn 12, Issue 3, 2013, Pages 187-194

  Salem, Samar Abdallah M ^a   Abdel Fattah, Nermeen Sa ^a   Tantawy, Samah Ma ^a   El Badawy, Nafissa Ma ^a   Abd El Aziz, Yasser A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Nd YAG; Neodymium yttrium aluminum garnet laser; PDL; Pulsed dye laser; Rosacea; Substance (P)

Indexed keywords

AZELAIC ACID; ISOTRETINOIN; METRONIDAZOLE; TETRACYCLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW LEVEL LASER THERAPY; NEODYMIUM YAG LASER; PATIENT ASSESSMENT; PRIORITY JOURNAL; PULSED DYE LASER; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SELF EVALUATION; TELANGIECTASIA;

ND-YAG; NEODYMIUM-YTTRIUM ALUMINUM GARNET LASER; PDL; PULSED DYE LASER; ROSACEA; SUBSTANCE (P);

ADULT; ERYTHEMA; FEMALE; HUMANS; LASERS, DYE; LASERS, SOLID-STATE; MIDDLE AGED; ROSACEA; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; TELANGIECTASIS;

EID: 84883428442     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/jocd.12048     Document Type: Article

References (19)

1. Crawford GH, Pelle MT, James WD. Rosacea 1 Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 5: 327-41.
2. Beuchner SA. Rosacea: an update. Dermatol 2005; 210: 100-8.
3. Roebuck HL. Face up to rosacea. Nurse Pract 2005; 30: 24-30.
4. Powell F, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol 1993; 28: 132-3.
5. Lonne-Rahm S, Nordlind K, Edström DW et al. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol 2004; 140: 1345-9.
6. Wilkin J, Dahl M, Detmar M et al, National Rosacea Society Expert Committee. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907-12.
7. van Zuuren EJ, Kramer SF, Carter BR et al. Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review. Br J Dermatol 2011; 165: 760-81.
8. Srinivas CR, Kumaresan M. Lasers for vascular lesions: standard guidelines for care. Indian J Dermatol Venereol Leprol 2011; 77: 349-68.
9. Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg 2009; 35: 920-8.
10. Goldman MP, Weiss RA, Brody HJ et al. Treatment of facial telangiectasia with sclerotherapy, laser surgery and/or electrodessication: a review. J Dermatol Surg Oncol 1993; 19: 899-906.
11. Bowes LE, Goldman MP. Sclerotherapy of reticular and telangiectatic veins of the face, hand, and chest. Dermatol Surg 2002; 28: 46-51.
12. Alster TS. Laser treatment of vascular lesions: recent trends. Cosmetic Derm 2000; 47: 51-3.
13. Eremia S, Li CY. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd-YAG laser: a prospective study of 17 patients. Dermatol Surg 2002; 28: 244-7.
14. Goldman MP. Optimal management of facial telangiectasia. Am J Clin Dermatol 2004; 5: 423-4.
15. Tanghetti EA. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med 2012; 44: 97-102.
16. Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol 2004; 51: 592-9.
17. Lowe NJ, Behr KL, Fitzpatrick RE et al. Flash lamp pulsed dye laser for rosacea-associated telangiectasia and erythema. J Dermatol Surg Oncol 1991; 17: 522-5.
18. Mariéthoz E, Polla EM, Gonzalez M. Treatment of facial telangiectasia: a new application of flash lamp-pumped dye lasers. J Dermatol Treat 2000; 11: 181-4.
19. Bäumler W, Ulrich H, Hartl A et al. Optimal parameters for the treatment of leg veins using Nd: YAG lasers at 1064 nm. Br J Dermatol 2006; 155: 365-71.